Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis

被引:0
|
作者
Van Der Meeren, Olivier [1 ]
Crasta, Priya [2 ]
Cheuvart, Brigitte [1 ]
De Ridder, Marc [1 ]
机构
[1] GSK Vaccines, Wavre, Belgium
[2] GSK Vaccines, Bangalore, Karnataka, India
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1726 / 1728
页数:3
相关论文
共 50 条
  • [21] IMMUNOGENICITY OF PRE-S PLUS-S HEPATITIS-B VACCINE IN HEALTHY-ADULTS
    KATKOV, WN
    WATKINS, E
    CODY, H
    DIENSTAG, JL
    HEPATOLOGY, 1990, 12 (04) : 879 - 879
  • [22] The effect of HLA on immunological response to hepatitis B vaccine in healthy people: A meta-analysis
    Li, Zheng-Kang
    Nie, Jing-Jing
    Li, Jie
    Zhuang, Hui
    VACCINE, 2013, 31 (40) : 4355 - 4361
  • [23] PERSISTENCE OF ANTI-HBS TITERS IN HEALTHY-ADULTS FOLLOWING VACCINATION WITH A RECOMBINANT DNA HEPATITIS-B VACCINE
    JUST, M
    SAFARY, A
    BOSCIA, J
    MOONSAMMY, G
    ANDRE, F
    HEPATOLOGY, 1989, 10 (04) : 692 - 692
  • [24] Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens
    Betancourt, Aristides Aguilar
    Delgado, C. A. Gonzalez
    Estevez, Z. Cinza
    Martinez, J. Cabrera
    Rios, G. Veliz
    Aureoles-Rosello, S. R. Moreno
    Zaldivar, R. Aleman
    Guzman, M. Alonso
    Baile, N. Figueroa
    Reyes, P. A. Dias
    Ruano, L. Olivera
    Fernandez, A. Correa
    Lobaina-Matos, Y.
    Fernandez, A. Delahanty
    Madrazo, A. I. Juvier
    Martinez, M. I. Alonso
    Banos, M. Lago
    Alvarez, N. Puble
    Baldo, M. David
    Mestre, R. E. Soto
    Perez, M. V. Perez
    Martinez, M. E. Pena
    Escobar, D. Acosta
    Guanche, M. J. Cerna
    Caceres, L. Mila
    Betancourt, R. Sanchez
    Rando, E. Hardy
    Nieto, G. E. Guillen
    Gonzalez, V. L. Muzio
    Rubido, J. C. Aguilar
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (05) : 394 - 401
  • [25] Critical role of B cell lineage in dictating response and non-response to hepatitis B vaccine; A retrospective and prospective study with healthy adults
    Doi, Hiroyoshi
    Yoshio, Sachiyo
    Sakamoto, Yuzuru
    Shimagaki, Tomonari
    Kawai, Hironari
    Nishida, Nao
    Osawa, Yosuke
    Yoshida, Hitoshi
    Yoneyama, Keiichiro
    Mizokami, Masashi
    Kanto, Tatsuya
    HEPATOLOGY, 2017, 66 : 1002A - 1002A
  • [26] High seroprotection rate induced by intradermal administration of a recombinant hepatitis B vaccine in young healthy adults: Comparison with standard intramuscular vaccination
    Ghabouli, MJ
    Sabouri, AH
    Shoeibi, N
    Bajestan, SN
    Baradaran, H
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2004, 19 (09) : 871 - 875
  • [27] A comparative trial of two surface subunit recombinant hepatitis B vaccines vs a surface and PreS subunit vaccine for immunization of healthy adults
    Eyigun, CP
    Yilmaz, S
    Gul, C
    Sengul, A
    Hacibektasoglu, A
    Van Thiel, DH
    JOURNAL OF VIRAL HEPATITIS, 1998, 5 (04) : 265 - 269
  • [28] High seroprotection rate induced by intradermal administration of a recombinant hepatitis B vaccine in young healthy adults: Comparison with standard intramuscular vaccination
    Ghabouli M.J.
    Sabouri A.H.
    Shoeibi N.
    Naghibzadeh Bajestan S.
    Baradaran H.
    European Journal of Epidemiology, 2004, 19 (9) : 871 - 875
  • [29] Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene®) in healthy adults
    Rebedea, I.
    Diaconescu, I. G.
    Bach, D.
    Bartelsen, O.
    Arndtz, N.
    VACCINE, 2006, 24 (25) : 5320 - 5326
  • [30] IMMUNOGENICITY, REACTOGENICITY AND ANTIBODY PERSISTENCE OF A YEAST DERIVED RECOMBINANT-DNA HEPATITIS-B VACCINE IN HEALTHY-YOUNG ADULTS
    TILZEY, AJ
    LAIDLER, PW
    ANATVAL, JEB
    JOURNAL OF MEDICAL VIROLOGY, 1987, 21 (04) : A100 - A100